Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KORU Medical Systems, Inc.
Report date December 18, 2018 · Filed December 19, 2018
Section 16 reporting ended · disclosed 2018-12-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-18 transaction · row 1
1 source rowRow 1 · 2018-12-18 · Sale · Disposed 748,047 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 50,000 |
Reported balance
After 2018-12-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-12-18 · Sale · Disposed 1,071,500 · Balance 50,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2018 Filed Dec 19, 2018 21:20 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | SaleCommon Stock | 1,071,500 | $1.13 | $1,208,652.00 |
DisclosureSEC source: 0001161697-18-000593 · form_4.xml · nonDerivative · entry 2 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 50,000 Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 21:20 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | SaleCommon Stock | 748,047 | $1.13 | $843,797.02 |
DisclosureSEC source: 0001161697-18-000593 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 22:06 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 1,894 | $1.65 | $3,125.10 |
DisclosureSEC source: 0001161697-18-000470 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,869,747 Read SEC document |
| September 28, 2018 Filed Dec 19, 2018 21:18 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 1,894 | $1.65 | $3,125.10 |
DisclosureSEC source: 0001161697-18-000591 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 748,047 F1 · security: The original Form 4, filed on 10/2/18, incorrectly reported the amount of securities beneficially owned following reported transaction (i) as all beneficially owned directly by the reporting person wherein only a portion was directly owned by the reporting person and a portion was owned by the reporting person's wife, and (ii) including an additional 200 shares that are not beneficially owned, directly or indirectly, by the reporting person. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:48 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,264 | $1.38 | $3,124.32 |
DisclosureSEC source: 0001161697-18-000355 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,867,853 Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 19:59 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,404 | $1.30 | $3,125.20 |
DisclosureSEC source: 0001161697-18-000174 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,865,589 Read SEC document |
| December 29, 2017 Filed Jan 2, 2018 22:41 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 2,500 | $1.25 | $3,125.00 |
DisclosureSEC source: 0001161697-18-000012 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863,185 Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 01:48 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 5,896 | $0.53 | $3,124.88 |
DisclosureSEC source: 0001161697-17-000433 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860,685 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:58 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 8,866 | $0.47 | $4,167.02 |
DisclosureSEC source: 0001161697-17-000310 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,854,789 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:24 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000143 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838,570 Read SEC document |
| March 01, 2017 Filed May 2, 2017 21:42 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 7,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000226 · form_4.xml · nonDerivative · entry 2 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,845,923 Read SEC document |
| March 01, 2017 Filed May 2, 2017 21:42 UTC Amendment | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 6,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-17-000226 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838,570 Read SEC document |
| October 27, 2016 Filed Oct 27, 2016 21:59 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 7,102 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-16-001159 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,831,777 Read SEC document |
| September 29, 2016 Filed Oct 3, 2016 20:36 UTC | KORU Medical Systems, Inc. REPR · Entity 6517 | GrantCommon Stock | 8,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001161697-16-001099 · form_4.xml · nonDerivative · entry 1 Baker Paul Mark · CIK 0001329500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,824,675 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.